Medigene AG reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 6.03 million compared to EUR 31.25 million a year ago. Net loss was EUR 16.18 million compared to EUR 8.33 million a year ago.

Basic loss per share from continuing operations was EUR 0.66 compared to EUR 0.34 a year ago.